Breaking News Instant updates and real-time market news.

TXMD

TherapeuticsMD

$5.74

-1.05 (-15.46%)

08:35
11/30/16
11/30
08:35
11/30/16
08:35

TherapeuticsMD short thesis a 'hodgepodge' that ignores '001, says Jefferies

Jefferies analyst Matthew Andrews attributes yesterday's slide in TherapeuticsMD to a short thesis presented by an investor at the Robin Hood Conference, though he views the thesis as a "hodgepodge" of topics, many of which have already been expressed by bears. Andrews said nothing in the short call impacts his expectation for positive REPLENISH trial data and sales of Yuvvexy and TX-001HR. He keeps a Buy rating and $18 price target on TherapeuticsMD shares.

TXMD TherapeuticsMD
$5.74

-1.05 (-15.46%)

11/21/16
OPCO
11/21/16
INITIATION
Target $12
OPCO
Outperform
TherapeuticsMD initiated with an Outperform at Oppenheimer
Oppenheimer analyst Jay Olson started TherapeuticsMD with an Outperform rating and $12 price target.
11/22/16
JEFF
11/22/16
INITIATION
Target $18
JEFF
Buy
TherapeuticsMD assumed with a Buy at Jefferies
Jefferies analyst Matthew Andrews assumed coverage of TherapeuticsMD with a Buy rating and $18 price target. The analyst expects positive TX-001HR data in the coming weeks and believes the risk/reward is favorable going into the hormone replacement therapy data.
11/29/16
GUGG
11/29/16
NO CHANGE
GUGG
TherapeuticsMD selloff a buying opportunity, says Guggenheim
Guggenheim analyst Louise Chen believes weakness in TherapeuticsMD is a compelling buying opportunity. Chen said the weakness appears to be driven by a short presentation which sounds like a "rehash" of a prior short thesis published on the blog site "SeekingAlpha.com" with little new information. The analyst expects positive data for TX-001HR in 4Q16, and potential approval for Yuvvexy on its PDUFA date of 5/7/17, both of which she believes have blockbuster potential. Chen has a Buy rating on TherapeuticsMD shares.
11/30/16
STFL
11/30/16
NO CHANGE
STFL
TherapeuticsMD Phase III trial likely to be successful, says Stifel
Stifel analyst Annabel Samimy expects the Phase III trial of TherapeuticsMD's estradiol+progesterone for the treatment of vasomotor symptoms in menopausal women to show that the three highest doses of the company's drug are "efficacious." The analyst says that estradiol has successfully reduced VMS symptoms in prior trials. She keeps a $14 price target and a Buy rating on the shares.

TODAY'S FREE FLY STORIES

SGM

Stonegate Mortgage

$7.96

-0.0059 (-0.07%)

15:29
04/26/17
04/26
15:29
04/26/17
15:29
Conference/Events
Stonegate Mortgage to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

NOW

ServiceNow

$90.00

-0.24 (-0.27%)

15:20
04/26/17
04/26
15:20
04/26/17
15:20
Options
ServiceNow options imply 10.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 12

    Jun

MS

Morgan Stanley

$44.50

0.225 (0.51%)

15:18
04/26/17
04/26
15:18
04/26/17
15:18
Conference/Events
Morgan Stanley management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

  • 22

    May

TRU

TransUnion

$39.72

0.92 (2.37%)

15:17
04/26/17
04/26
15:17
04/26/17
15:17
Conference/Events
TransUnion management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 09

    May

$NSD

NASDAQ Market Internals

15:17
04/26/17
04/26
15:17
04/26/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRB

H&R Block

$24.07

-0.175 (-0.72%)

, INTU

Intuit

$119.08

0.32 (0.27%)

15:17
04/26/17
04/26
15:17
04/26/17
15:17
Hot Stocks
Trump Effect: Tax preparers fall as administration promises simpler code »

Shares of publicly-traded…

HRB

H&R Block

$24.07

-0.175 (-0.72%)

INTU

Intuit

$119.08

0.32 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZION

Zions Bancorp

$40.49

-1.47 (-3.50%)

15:16
04/26/17
04/26
15:16
04/26/17
15:16
Conference/Events
Zions Bancorp management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

$NYE

NYSE Market Internals

15:16
04/26/17
04/26
15:16
04/26/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$40.34

0.4 (1.00%)

15:14
04/26/17
04/26
15:14
04/26/17
15:14
Hot Stocks
AT&T, IBEW reach tentative agreement in Midwest wireline contract negotiations »

AT&T announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 16

    May

  • 17

    May

ALNY

Alnylam

$51.35

1.05 (2.09%)

, IONS

Ionis Pharmaceuticals

$47.88

2.14 (4.68%)

15:12
04/26/17
04/26
15:12
04/26/17
15:12
Recommendations
Alnylam, Ionis Pharmaceuticals analyst commentary  »

Alnylam data for…

ALNY

Alnylam

$51.35

1.05 (2.09%)

IONS

Ionis Pharmaceuticals

$47.88

2.14 (4.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 09

    May

  • 12

    May

  • 24

    May

  • 06

    Jun

VIX

Volatility Index S&P 500 Options

$10.47

-0.29 (-2.70%)

15:11
04/26/17
04/26
15:11
04/26/17
15:11
Options
Quiet day in the VIX pit as markets see muted reaction to Trump's tax plan »

Quiet day in the VIX pit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STX

Seagate

$50.51

1.09 (2.21%)

15:10
04/26/17
04/26
15:10
04/26/17
15:10
Recommendations
Seagate analyst commentary  »

Needham would be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    Jun

FFIV

F5 Networks

$138.19

0.26 (0.19%)

15:05
04/26/17
04/26
15:05
04/26/17
15:05
Options
F5 Networks options imply 9.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

USB

U.S. Bancorp

$52.47

0.34 (0.65%)

15:01
04/26/17
04/26
15:01
04/26/17
15:01
Hot Stocks
U.S. Bank names Kate Quinn chief administrative officer »

U.S. Bank announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 19

    Jul

  • 18

    Oct

  • 17

    Jan

T

AT&T

$40.26

0.32 (0.80%)

15:00
04/26/17
04/26
15:00
04/26/17
15:00
Hot Stocks
AT&T CEO 'applauds' FCC initiative to remove 'regulatory cloud' over internet »

AT&T Chairman &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 16

    May

  • 17

    May

AMZN

Amazon.com

$907.62

0.21 (0.02%)

14:55
04/26/17
04/26
14:55
04/26/17
14:55
Hot Stocks
Amazon debuts 'Echo Look' camera, style assistant »

Amazon debuted its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 16

    May

  • 16

    May

  • 23

    May

MENB

Mendocino Brewing Company, Inc.

14:52
04/26/17
04/26
14:52
04/26/17
14:52
Hot Stocks
Mendocino Brewing Company gets amendment to current credit facility »

Effective April 25,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNX

Mellanox

$50.95

-0.55 (-1.07%)

14:50
04/26/17
04/26
14:50
04/26/17
14:50
Options
Mellanox options imply 9.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 12

    Jun

TWTR

Twitter

$15.99

1.325 (9.04%)

14:47
04/26/17
04/26
14:47
04/26/17
14:47
Recommendations
Twitter analyst commentary  »

Twitter to be valued like…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ILG

ILG

$23.68

0.57 (2.47%)

14:41
04/26/17
04/26
14:41
04/26/17
14:41
Options
Notable interest in ILG in-the-money calls »

Notable interest in ILG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 25

    May

III

Information Services

$3.19

-0.02 (-0.62%)

14:38
04/26/17
04/26
14:38
04/26/17
14:38
Conference/Events
Information Services management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 09

    May

COF

Capital One

$83.86

-1.725 (-2.02%)

14:38
04/26/17
04/26
14:38
04/26/17
14:38
Downgrade
Capital One rating change  »

Capital One downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 31

    May

  • 06

    Jun

MCRN

Milacron

$19.17

0.37 (1.97%)

14:37
04/26/17
04/26
14:37
04/26/17
14:37
Hot Stocks
Milacron says DME subsidiary to expand Greenville facility »

Milacron Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 16

    May

  • 16

    May

SAGE

SAGE Therapeutics

$73.37

0.52 (0.71%)

14:36
04/26/17
04/26
14:36
04/26/17
14:36
Options
Sage Therapeutics put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

CB

Chubb

$139.25

2.13 (1.55%)

14:32
04/26/17
04/26
14:32
04/26/17
14:32
Recommendations
Chubb analyst commentary  »

Chubb price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 18

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.